{
    "Trade/Device Name(s)": [
        "AmnioStat-FLM-PG",
        "AmnioStat"
    ],
    "Submitter Information": "Irvine Scientific Sales Co., Inc.",
    "510(k) Number": "K061549",
    "Predicate Device Reference 510(k) Number(s)": [
        "K822150"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHG"
    ],
    "Summary Letter Date": "September 25, 2006",
    "Summary Letter Received Date": "September 26, 2006",
    "Submission Date": "June 2, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1455"
    ],
    "Regulation Name(s)": [
        "Lecithin/sphingomyelin ratio in amniotic fluid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Phosphatidylglycerol"
    ],
    "Specimen Type(s)": [
        "Amniotic fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Disposable agglutination card"
    ],
    "Method(s)/Technology(ies)": [
        "Immunological semi-quantitative agglutination test"
    ],
    "Methodologies": [
        "Agglutination"
    ],
    "Submission Type(s)": [
        "Kit",
        "Control",
        "Reagent",
        "Buffer",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for AmnioStat-FLM-PG immunological agglutination test kit for phosphatidylglycerol detection in amniotic fluid indicating fetal lung maturity",
    "Indications for Use Summary": "Intended for immunologic semiquantitative detection of phosphatidylglycerol in human amniotic fluid at concentrations indicative of fetal lung maturity for use by laboratory personnel in hospital or clinical laboratory settings",
    "fda_folder": "Clinical Chemistry"
}